Clin2
NCT06963203Likely a fitRecruiting

Surgery for hyperthyroidism from Graves' or amiodarone use

Graves DiseaseAmiodarone-Induced ThyrotoxicosisThyroidectomy

Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.

This study looks at thyroid removal surgery for hyperthyroidism caused by Graves' disease or the heart medication amiodarone. It aims to see how well the surgery works for these patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
486 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 years or older.
  • You have Graves' disease or amiodarone-caused hyperthyroidism.
  • Your hyperthyroidism is confirmed by blood tests or you are taking specific medication for it.
  • You are willing and able to give informed consent for the study.
  • You are not pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07059507Recruiting
Thyroid cancer in Graves' disease patients having thyroid surgery

This study looks at how often thyroid cancer is found by accident in people with Graves' disease who have their thyroid removed. It helps doctors understand who might be at higher risk so they can plan better care.

Minya, Minya Governorate
NCT07018323Recruiting· Phase 2
Study of IMVT-1402 for Graves' disease

This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.

Tucson, Arizona
NCT06727604Recruiting· Phase 2
Study of IMVT-1402 for Graves' disease not controlled by medication

This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.

Phoenix, Arizona
NCT07661056Recruiting· Phase 3
A drug trial for adults with Graves' disease

This trial is testing a new drug, BHV-1300, to see if it works and is safe for people with Graves' disease. It might be an option if you have active hyperthyroidism (overactive thyroid) caused by Graves' disease and haven't had certain other treatments.

Burbank, California
NCT05461820Recruiting· Phase 4
Testing treatment options for Graves’ disease and its relapse

This study compares different treatment plans to see how well they control Graves’ disease and whether it comes back. It may help by identifying which approach works best to prevent relapse.

Nanjing
NCT07017907Recruiting
AI tool for detecting thyrotoxic states

This study tests an artificial intelligence tool designed to help detect overactive thyroid conditions (thyrotoxicosis). It may be an option for people with Graves' disease, whether newly diagnosed or currently in treatment.

San Francisco, California

Hear when a new Graves Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.